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Abstract
Background: Cancer chemotherapy is still hampered by clinical failures due to multi-drug resistance (MDR) of
tumor cells. In the present study, we have investigated the cytotoxicity of 20 methanol extracts from 10 medicinal
plants against the sensitive leukemia CCRF-CEM cells. The most cytotoxic extracts were then further tested on a
panel of 8 human cancer cell lines, including various MDR phenotypes.
Methods: The cytotoxicity of the 20 methanol extracts from 10 Cameroonian medicinal plants was determined
using a resazurin reduction assay. Meanwhile, flow cytometry was used to measure cell cycle, apoptosis,
mitochondrial membrane potential (MMP), and reactive oxygen species (ROS).
Results: In the preliminary assay using CCRF-CEM cells, 12 extracts from five plants displayed IC50 values below
80 μg/mL, namely Albizia adianthifolia, Alchornea cordifolia, Alchornea laxiflora, Pennisetum purpureum, and Spathodea
campanulata. the four best extracts were from two plants: Albizia adianthifolia roots (AAR) and bark (AAB) as well as
Alchornea cordifolia leaves (ACL) and bark (ACB) had respective IC50 values of 0.98 μg/mL, 1.45 μg/mL, 8.02 μg/mL and
12.57 μg/mL in CCRF-CEM cells. They were further tested in 8 other cell lines as well as in normal AML12 hepatocytes.
IC50 values ranging from 2.71 μg/mL (towards glioblastoma U87MG.ΔEGFR cells) to 10.30 μg/mL (towards breast
adenocarcinoma MDA-MB-231-BCRP cells) for AAB, from 3.43 μg/mL (towards U87MG cells) to 10.77 μg/mL (towards
colon carcinoma HCT116 (p53−/−) cells) for AAR and from 0.11 μg/mL (towards CCRF-CEM cells) to 108 μg/mL (towards
leukemia CEM/ADR5000 cells) for doxorubicin (as control drug) were obtained. ACL and ACB extracts displayed
selective activities. AAR and ACL extracts induced apoptosis in CCRF-CEM cells, through caspases activation and
loss of MMP, while apoptotic cell death was mediated by MMP diruption and increase ROS production for ACL.
Conclusion: Some of the tested plants namely Albizia adianthifolia, Alchornea cordifolia, Alchornea laxiflora,
Pennisetum purpureum, Spathodea campanulata represent a potential source of novel anticancer drugs. Especially,
Albizia adianthifolia and Alchornea cordifolia revealed considerable cytotoxic activities that could be exploited to
develop phytomedicines to fight cancers including MDR phenotypes.
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Background
Malignant diseases are amongst the major causes of death
worldwide with a growing burden and low survival rates in
developing countries [1]. Clinically, chemotherapy is still
hampered by treatment failures due to multidrug resist-
ance (MDR) of cancer cells. Anticancer drug development
should take into account the fact that cancer cells rapidly
acquire resistance [2–5]. Natural ressources such as medi-
cinal plants constitute an indeniable reservoir of antiprolif-
erative compounds [6]. Hence, fighting cancers and mostly
drug-resistant phenotypes with phytochemical represents
a very promising alternative, especially regarding the diver-
sity of plant’s secondary metabolites. In the past, several
bioactive compounds belonging to several classes of sec-
ondary metabolites isolated from African plants showed
considerable antiproliferative activity against MDR cancer
cells. Some of these molecules include benzophenones
(2,2′,5,6′-tetrahydroxybenzophenone, guttiferone E, isogar-
cinol and isoxanthochymo) [7], xanthones (xanthone V1,
quinones: 2-acetylfuro-1,4-naphthoquinone) [8], flavonoids
(gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin,
6,8-diprenyleriodictyol [9], 2′,4′-dihydroxy-3′,6′-dimethox-
ychalcone, 4′-hydroxy-2′,6′-dimethoxychalcone, carda-
momin [10, 11], 8-hydroxycudraxanthone G, morusignin I
and cudraxanthone I [12] and alkaloids (isotetrandrine
[13], montrofoline, 1-hydroxy-4-methoxy-10-methylacri-
done, norevoxanthine, evoxanthine and 1,3-dimethoxy-
10-methylacridone) [14]. Moreover, several African
medicinal plants previously displayed good cytotoxicity
towards drug-sensitive and drug-resistant cancer cell
lines. These plants include Echinops giganteus, Xylopia
aethiopica, Piper capense, Imperata cylindrica [15, 16],
Beilschmiedia acuta, Clausena anisata, Fagara tessmannii,
Newbouldia laevis, Polyscias fulva [17], Garcina lucida,
Fagara heitzii, Hymenocardia lyrata [18], Gladiolus quar-
tinianus,Vepris soyauxii and Anonidium mannii [19].
In our ongoing search of anticancer drugs from African
medicinal plants, we undertook the present work to assess
the cytotoxicity of 10 Cameroonian medicinal plants trad-
itionally used to manage cancer or disease states bearing
relevance to cancer or cancer-like symptoms, such as im-
mune and skin disorders, inflammatory, infectious, para-
sitic and viral diseases [15]. The study was extended to
the evaluation of the ability of extracts from two most
active plants, Albizia adianthifolia and Alchornea cor-
difolia to alter the cell cycle distribution, caspases activ-
ity, mitochondrial membrane potential (MMP) and to
increase reactive oxygen species (ROS) in leukemia
CCRF-CEM cells.
Methods
Plant material and extraction
All medicinal plants parts used in the present study were
collected in different regions of Cameroon in January
2014. These included leaves, bark and roots of Alchornea
cordifolia, Alchornea laxiflora, Albizia adianthifolia and
Spathodea campanulata, leaves and roots of Combretum
hispidum and Laportea ovalifolia and the whole plant of
Boerhavia diffusa, Eremomastax speciosa, Laportea aes-
tuans and Pennisetum purpureum. The plants were iden-
tified at the National Herbarium (Yaoundé, Cameroon),
where voucher specimens were deposited under the refer-
ence numbers shown in Table 1. The air-dried and pow-
dered plant material was soaked in methanol for 48 h, at
room temperature. The methanol extract was concen-
trated in vacuum under reduced pressure to give the
crude extract. This extract was then conserved at 4 °C
until further use.
Chemicals
Doxorubicin 98.0 % and vinblastine ≥ 96 % from Sigma-
Aldrich (Munich, Germany) were provided by the Uni-
versity Pharmacy of the Johannes Gutenberg University
(Mainz, Germany) and dissolved in phosphate buffer sa-
line (PBS; Invitrogen, Eggenstein, Germany) at a concen-
tration of 10 mM. Geneticin > 98 % (Sigma-Aldrich) was
stored at a stock concentration of 72.18 mM.
Cell cultures
The cell lines used in the present study, their origins
and their treatments were previously reported. They in-
clude drug-sensitive leukemia CCRF-CEM and multidrug-
resistant P-glycoprotein-over-expressing subline CEM/
ADR5000 cells [4, 20, 21], breast cancer MDA-MB-231-
pcDNA3 cells and its resistant subline MDA-MB-231-
BCRP clone 23 [22], colon cancer HCT116 (p53+/+) cells
and its knockout clone HCT116 (p53−/−), glioblastoma
U87MG cells and its resistant subline U87MG.ΔEGFR
[7, 12, 16]. Leukemia CCRF-CEM and CEM/ADR5000
cells were cultured in RPMI 1640 medium (Invitrogen)
supplemented with 10 % fetal calf serum in a humidi-
fied 5 % CO2 atmosphere at 37 °C. This medium was
also used for the cytotoxicity test with these two cell lines.
MDA-MB-231-BCRP as well as U87MG.ΔEGFR and
HCT116 (p53−/−) were maintained in DMEM medium
containing 10 % FBS (Invitrogen) and 1 % penicillin (100
U/mL)-streptomycin (100 μg/mL) (Invitrogen) and were
continuously treated with 800 ng/mL and 400 μg/mL ge-
neticin, respectively. The cytotoxicity of all carcinoma
cells was performed in DMEM medium containing 10 %
FBS (Invitrogen) and 1 % penicillin-streptomycin.
Resazurin reduction assay
The cytotoxicity of the tested samples was performed by
resazurin reduction assay as previously described [7, 23].
The assay is based on reduction of the indicator dye,
resazurin, to the highly fluorescent resorufin by viable
cells. Non-viable cells rapidly lose the metabolic capacity
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Table 1 Published bioactivity and phytochemistry of the studied plants
Species (family); Voucher
Numbera
Traditional uses Parts used (% yield)b Bioactive or potentially bioactive components Bioactivity of crude extract
Albizia adianthifolia (Schum.)
(Fabaceae); 24729/SRF/Cam
Treatment skin diseases, bronchitis,
inflamed eyes, tapeworm, headaches
and sinusitis [33, 34]
Leaves (9.88), bark (10.65)
and roots (7.12)
Adianthifoliosides A, B, D [30, 35], lupeol and
aurantiamide acetate [32], prosapogenins [31]
Antimicrobial effect of crude extract
against Ec, Ef, Pa, Pm, Kp, Sa, Sf, St, Ca, Ct,
Ck, Cg, Cl, Cn [32, 36]; aqueous extract:
antioxidant [32, 37]
Alchornea cordifolia (Schum. &
Thonn.) Müll.-Arg. (Euphorbiaceae);
9657/SRF/Cam
Treat rheumatic pains, fever, wounds,
diarrhea, convulsions, coughs,
gonorrhoea, yaws, ulcer, rheumatic
pains, bronchial troubles [38, 39]
Leaves (7.84), bark (11.32)
and roots (6.23)
Alchornine, alchorneinone, gentisnic acid and
yohimbine [38]
Crude extract showed: spasmolytic [38],
anti-inflammatory [40], anti-microbial
[41],[42], anti-diarrheal [43] and analgesic
[44] activities
Alchornea laxiflora (Benth.) Pax &
K Hoffm. (Euphorbiaceae); 9661/
SRF/Cam
Treatment of inflammatory and
infectious diseases, poliomyelitis
and measles. [45, 46]





Methanol fraction of leave extracts :
antimicrobial on Ba, Bc, Ec, Kp, Pa, Pf, Sa,




Treatment of diabetes, asthma,
bronchial infections [49]
Whole plant (11.42) Boeravinones G, H [50] Crude extract of leaves: Antioxidant and
hepatoprotective properties [51],
antimicrobial activity of crude extract
agains: Pa, Ec, St, Sf [52], Kp, Ea, Ps [36]
Combretum hispidum Laws
(Combretaceae); 48289/HNC
Treatment of stomach aches,
diarrhea, gastro-intestinal disorders,
liver complaints, skin infections,
urinary tract infections [53–55]
Leaves (14.32), roots (8.47) Alkaloids, polyphenols, flavonoids, anthraquinones,
coumarins, tannins, triterpenes, sterols ans
saponins [36]
Crude extract of bark: anti-hepatoxic,
anti-inflammatory, antiparasitic, mollucidal
effect [56], Antimicrobial effect of crude





antiulcer, treatment of female
infertility, dysentery, anemia, irregular
menstruation, fracture, hemorrhoids
and urinary tract infections [57, 58]
Whole plant (14.69) Alkaloids, polyphenols, flavonoids, tannins,
triterpenes, sterols ans saponins [42]
Antimicrobial effect of crude extract
against Ec, Sa, Ca [59], Ec, Pa, Ea, Ps [42]
Laportea aestuans (Linn.) Chew
(Urticaceae); 34812/HNC
Antihelmintic, treatment of





Whole plant (8.82) Vanilic acid, gallic acid, ferulic acid, (6)-gingerol,
capsaicin, rosemamic acid, tannic acid, p-coumaric
acid, caffeic acid, scopoletin, catechin, resveratrol,
genistein, apigenin, kaempherol, epicatechin,
epigallocathechin, ellagic acid, myricitin acid,
quercetin- 3, 7, 4-trimethyl ether, quercetin–3,7,3′,
4′-trimethyl ether, artemetin, kaempferol–arabinoside,
quercitrin, isoquercitrin, naringin, rutin, hesperidin,
limonene, α-pinene, β-pinene, cis-ocimene, myrcene,
citronellol, neryl acetate, malvidine, lycopene,
carotene, lutein, hispogenin, diosgenin, neochlorogenin,
hecogenin, [61, 62]
Antimicrobial effect of crude extract
against; K, Ec, Sa, Bs, St, Pa, Ca, [61, 63]
Ec, Pa, Kp, Ea, Ps [42]
Laportea ovalifolia (Schum.)
Chew (Urticaceae) 44306/HNC
Treatment of headache, internal
ulcers, diabetes, bronchitis and
wired [64, 65]
Leaves (12.13) and roots
(6.17)
Laportoside A and laportomide A [66] Crude extract of leaves: antidiabetic and
hypolipidaemic effects [65], and crude























of measles, wound healing [67]
Whole plant (8.82) Alkaloids, polyphenols, flavonoids, tannins,
triterpenes, sterols ans saponins [42]
Antimicrobial effect of EO: Ec, Pa [67] and
crude extract against Ec, Kp, Pa, Ea, Ps [42]
Spathodea campanulata P. Beauv.
(Bignoniaceae) 22791/SRF/Cam
Treatment of mental disorders,
malaria, hemorrhoids, bacterial
infections, HIV, poor blood
circulation, gastro-intestinal diseases,
urinary tract disorders [68]
Leaves (16.13), bark (15.27)
and roots (11.41)
Carbohydrates, alkaloids, tannins, iridoid
glucoside, phydroxy-benzoic acid, methyl
p-hydroxy-benzoate [68, 69]
Antimicrobial effect of against Pv, Ec, Kp
[70], Pa, Ea, Ps [42]
a(HNC): Cameroon National Herbarium; (SRF/Cam):Société des Réserves Forestières du Cameroun; byield calculated as the ratio of the mass of the obtained methanol extract/mass of the plant powder; EO Essential oil, As
Aspergillus niger, Ag Aspergillus glaucus, Af Aspergillus flavus, Ba Bacillus anthracis, Bc Bacillus cereus, Bs Bacillus subtilis, Ca Candida albicans, Cg Candida glabrata, CK Candida krusei, Cl Candida lusitaniae, Cn Cryptococcus
neoformans, Cp Candida pseudotropicalis, Ct Candida tropicalis, Ec Escherichia coli, Ea Enterobacter aerogenes, Ef Enterococcus faecalis, Kp Klebsiella pneumoniae, Pa Pseudomonas aeruginosa, Pf Pseudomonas fluorenscens,



















to reduce resazurin and thus produce no fluorescent sig-
nal. Briefly, adherent cells were detached by treatment
with 0.25 % trypsin/EDTA (Invitrogen) and an aliquot of
1x104 cells was placed in each well of a 96-well cell cul-
ture plate (Thermo Scientific, Germany) in a total vol-
ume of 200 μL. Cells were allowed to attach overnight
and then were treated with different concentrations of
the studied sample. For suspension cells, aliquots of 104
cells per well were seeded in 96-well-plates in a total
volume of 100 μL. The studied sample was immediately
added in varying concentrations in an additional 100 μL
of culture medium to obtain a total volume of 200 μL/
well. After 24 h or 48 h, 20 μL resazurin (Sigma-Aldrich,
Germany) 0.01 % w/v in ddH2O was added to each well
and the plates were incubated at 37 °C for 4 h. Fluores-
cence was measured on an Infinite M2000 Pro™ plate
reader (Tecan, Germany) using an excitation wavelength
of 544 nm and an emission wavelength of 590 nm. Each
assay was done at least two times, with six replicates each.
The viability was evaluated based on a comparison with
untreated cells. IC50 values represent the sample’s concen-
trations required to inhibit 50 % of cell proliferation and
were calculated from a calibration curve by linear regres-
sion using Microsoft Excel [8, 11]. The contribution of the
extracts (at various tested concentrations) to the fluores-
cence has been determined, both in the absence and pres-
ence of resazurin, prior to any cell studies. In a preliminary
study, all samples were tested against the sensitive CCRF-
CEM cells at various concentrations ranging from 0.63 to
80 μg/mL (crude extracts) or 0.08 to 10 μg/mL (doxorubi-
cin), and samples displaying IC50 values below 20 μg/mL
were further investigated in 8 other tumor cell lines as well
as in normal AML12 hepatocytes. Doxorubicin was used
as positive control, while dimethylsulfoxide (DMSO) used
to dissolve the samples was used as negative control. The
highest concentration of DMSO was less than 0.4 %.
Flow cytometry for cell cycle analysis and detection of
apoptotic cells
Extracts from Albizia adianthifolia roots (AAR) and
Alchornea cordifolia leaves (ACL) that displayed the best
cytotoxicity as well as doxorubicin were used to treat
CCRF-CEM cells (1 × 106) at their IC50 values. The cell
cycle was then analyzed after incubation for 24 h, 48 h and
72 h. All reagents, experimental conditions and apparatus
were identical to those previously reported [12, 16]. Briefly,
cell cycle analysis was performed by flow cytometry using
Vybrant® DyeCycle™ (Invitrogen, Darmstadt, Germany).
Cells were measured after Vybrant® DyeCycle™ Violet stain-
ing (30 min at 37 °C) on a LSR-Fortessa FACS analyzer
(Becton-Dickinson, Heidelberg, Germany) using the violet
laser. Vybrant® DyeCycle™ Violet stain was measured with
440 nm excitation. Cytographs were analyzed using FlowJo
software (Celeza, Switzerland). All experiments were per-
formed at least in triplicate.
Caspase-Glo 3/7, caspase-Glo 8 and caspase-Glo 9 assay
Caspase activity in CCRF-CEM cells treated with AAR
and ACL was detected using Caspase-Glo 3/7, Caspase-
Glo 8 and Caspase-Glo 9 Assay kits (Promega, Mannheim,
Germany) as previously described [24].
Analysis of mitochondrial membrane potential (MMP)
CCRF-CEM cells were treated with AAR, ACL or vinblast-
ine. The MMP was analyzed using 5,5′,6,6′-tetrachloro-
1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide)
(JC-1; Biomol, Hamburg, Germany) staining as previ-
ously described [19]. Cells were measured in a LSR-
Fortessa FACS analyzer (Becton-Dickinson). The JC-1
signal was measured at an excitation of 561 nm (150 mW)
and detected using a 586/15 nm band-pass filter. The signal
was analyzed at 640 nm excitation (40 mW) and detected
using a 730/45 nm bandpass filter. Cytographs were ana-
lyzed using FlowJo software (Celeza, Olten, Switzerland).
All experiments were performed at least in triplicate.
Measurement of reactive oxygen species (ROS)
by flow cytometry
The 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-
DA) (Sigma-Aldrich, Schnelldorf, Germany) was used
for the detection of ROS in CCRF-CEM cells treated
with AAR, ACL, DMSO (solvent control), or hydrogen
peroxide (H2O2; positive control) as previously described
[17, 25, 26]. Cells were measured in a FACS Calibur flow
cytometer (Becton-Dickinson). Dichlorofluorescein (DCF)
was measured at 488 nm excitation (25 mW) and detected
using a 530/30 nm band-pass filter. Cytographs were ana-
lyzed using FlowJo software (Celeza). All experiments
were performed at least in triplicate.
Statistical analysis
Statistical analysis of all data was performed using a Stu-
dent’s t-test or Kruskal–Wallis test followed by Dunn’s
post-hoc multiple comparison test (Graph-Pad Prism 5.01;
GraphPad Software, Inc., CA, USA). P < 0.05 denoted sig-
nificance in all cases.
Results
In the present investigation, the cytotoxicity of 20 metha-
nol extracts from 10 plants was first determined at differ-
ent concentrations in drug-sensitive CCRF-CEM leukemia
cells. The results are summarized in Table 2. Twelve out
of 20 (60 %) extracts displayed IC50 values below 80 μg/
mL. These extracts were from Pennisetum purpureum,
Spathodea campanulata bark, Spathodea campanulata
roots, Alchornea laxiflora bark, Alchornea laxiflora leaves,
Albizia adianthifolia leaves (AAL), Combretum hispidum
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leaves, Alchornea cordifolia roots (ACR), Alchornea cordi-
folia bark (ACB), Alchornea cordifolia leaves (ACL), Albi-
zia adianthifolia bark (AAB) and Albizia adianthifolia
roots (AAR). Extracts from Alchornea laxiflora roots,
Boerhavia diffusa (whole plant), Combretum hispidum
bark, Eremomastax speciosa (whole plant), Laportea aes-
tuans (whole plant), Laportea ovalifolia leaves, Laportea
ovalifolia roots, Spathodea campanulata leaves resulted
in more than 50 % proliferation of CCRF-CEM cells at
80 μg/mL (Table 2). Four extracts from two plants includ-
ing ACB (IC50 value of 12.57 μg/mL), ACL (IC50: 8.02 μg/
mL), AAB (IC50: 1.45 μg/mL) and AAR (IC50: 0.98 μg/mL)
as well as doxorubicin (IC50: 0.11 μg/mL) displayed IC50
values below 20 μg/mL in CCRF-CEM cells (Table 2).
These extracts were further selected for IC50 determination
towards a panel of sensitive and MDR cell lines. The results
summarized in Table 2 revealed IC50 values ranging from
2.71 μg/mL (towards glioblastoma U87MG.ΔEGFR cells)
to 10.30 μg/mL (towards breast adenocarcinoma MDA-
MB-231-BCRP cells) for AAB, from 3.43 μg/mL (to-
wards U87MG cells) to 10.77 μg/mL (towards resistant
colon carcinoma HCT116 (p53−/−) cells) for AAR and
from 0.11 μg/mL (towards CCRF-CEM cells) to 108 μg/mL
(towards P-glycoprotein-over-expressing CEM/ADR5000
cells) for doxorubicin on the 8 other cancer cell lines stud-
ied. Extracts from Alchornea cordifolia, ACL and ACB
displayed selective activities. However, ACL and ACB were
also less toxic towards normal AML12 hepatocytes,
with IC50 values above 80 μg/mL contrary to AAB
(IC50: 29.18 μg/mL) and AAR (IC50: 29.14 μg/mL). It is
worth noting that collateral sensitivity (or hypersensi-
tivity: higher toxicity to resistant than to sensitive cells
with a degree of resistance below 1) was observed in
drug-resistant epidermal growth factor receptor-transfected
U87MG.ΔEGFR cells to AAB (degree of resistance of 0.43-
fold), to AAR (0.39-fold), to ACL (0.83-fold) and to ACB
(<0.40-fold) compared to its sensitive counterpart U87MG
cells. Importantly, if cross-resistance to the tested extracts
were observed, the degrees of resistance were in all cases
lower than that of the reference compound, doxorubicin
(Table 3). AAR and ACL were the most active extracts from
Albizia adiathifolia and Alchornea cordifolia respectively,
and were subsequently used for mechanistic studies.
IC50 values of AAR and ACL extracts as well as doxo-
rubicin were used to treat CCRF-CEM cells for 6 h, and
the cycle distribution was analyzed. The results are
depicted in Fig. 1. Dose-dependent and significant modi-
fications of the cell cycle phases were observed. Both
AAR and ACL induced cell cycle arrest in the G0/G1
phase. After treatment with these two extracts, CCRF-
CEM cells underwent apoptosis with a dose-dependent
increase in the sub-G0/G1 phase. The percentages of
cells in the sub-G0/G1 phase varied from 32.14 % (in
24 h) to 57.99 % (72 h) and from 31.69 % (24 h) to
59.67 % (72 h), respectively, for AAR and ACL treat-
ments, while doxorubicin increased apoptosis in a range
of 6.02 % (24 h) to 51.87 % (72 h). The highest percent-
age of sub-G0/G1 phase in non-treated cells was only
6.42 % after 72 h. After treating CCRF-CEM cells for 6 h
at 2-fold IC50, AAR induced 4.35-fold, 2.02-fold and
1.52-fold increase of caspase 3/7, caspase 9 and caspase
8 activities, respectively, whereas no changes were ob-
served upon ACL treatment (Fig. 2). AAR also induced
significant MMP loss in a range of 35.5 % (1/2-fold IC50
treatment) to 87.6 % (2-fold IC50) (Fig. 3). ACL caused
up 41.7 % MMP loss at 1/2-fold IC50 treatment and
complete rupture of the membrane (99.7 %) at 2-fold
IC50 (Fig. 3). A 48.6 % loss of MMP at 2-fold IC50 of vin-
blastine was previously reported under similar experi-
mental conditions in CCRF-CEM cells [12]. AAR did
not induce ROS generation in CCRF-CEM cells contrary
to ACL (Fig. 4). Dose-dependant increase in ROS pro-
duction was also observed upon treatment of cells with
ACL in a range of 0.73 % (1/2-fold IC50 treatment) to
33.6 % (2-fold IC50).
Table 2 IC50 values (after 72 h) of the tested plant extracts
towards leukemia CCRF-CEM cells and as determined by the
resazurin assay
Tested plant IC50 values (μg/mL)
Alchornea laxiflora roots >80
Boerhavia diffusa (whole plant) >80
Combretum hispidum bark >80
Eremomastax speciosa (whole plant) >80
Laportea aestuans (whole plant) >80
Laportea ovalifolia leaves >80
Laportea ovalifolia roots >80
Spathodea campanulata leaves >80
Pennisetum purpureum (whole plant) 69.01 ± 7.99
Spathodea campanulata bark 63.29 ± 8.61
Spathodea campanulata roots 58.08 ± 4.27
Alchornea laxiflora bark 49.21 ± 11.16
Alchornea laxiflora leaves 43.67 ± 4.06
Albizia adianthifolia leaves (AAL) 33.34 ± 3.55
Combretum hispidum leaves 32.05 ± 2.41
Alchornea cordifolia roots (ACR) 27.28 ± 1.22
Alchornea cordifolia bark (ACB) 12.57 ± 0.55
Alchornea cordifolia leaves (ACL) 8.02 ± 0.23
Albizia adianthifolia bark (AAB) 1.45 ± 0.13
Albizia adianthifolia roots (AAR) 0.98 ± 0.08
Doxorubicin 0.11 ± 0.03
In bold: significant cytotoxic effect; Leukemia CCRF-CEM cells were tested in
RPMI 1640 medium supplemented with 10 % FBS and
1 % penicillin-streptomycin
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Table 3 Cytotoxicity of plant extracts and doxorubicin towards sensitive and drug-resistant cancer cell lines and normal cells as
determined by the resazurin assay after 72 h
Cell lines Samples, IC50 values in μg/mL and degrees of resistance
a (in brackets)
Extracts Doxorubicin
AAB AAR ACL ACB
CEM/ADR5000 6.53 ± 0.77 (4.50) 6.52 ± 0.57 (6.65) 22.57 ± 2.17 (2.81) 34.87 ± 3.91 (2.77) 108.00 ± 7.92 (975.60)
MDA-MB-231-pcDNA 5.99 ± 0.3 3.79 ± 0.44 29.51 ± 3.08 25.54 ± 3.01 0.61 ± 0.15
MDA-MB-231-BCRP Degree of resistance 10.30 ± 1.22 (1.72) 8.00 ± 1.01 (2.11) 35.42 ± 3.35 (1.20) 33.60 ± 2.14 (1.32) 4.33 ± 0.26 (7.12)
HCT116 (p53+/+) 5.13 ± 0.64 4.40 ± 0.32 33.15 ± 2.87 29.07 ± 2.68 0.78 ± 0.16
HCT116 (p53−/−) Degree of resistance 9.46 ± 0.88 (1.84) 10.77 ± 0.79 (2.45) >80 (>2.41) >80 (2.75) 2.25 ± 0.04 (2.88)
U87MG 6.29 ± 0.40 8.86 ± 0.69 38.63 ± 3.32 >80 0.59 ± 0.08
U87MG.ΔEGFR Degree of resistance 2.71 ± 0.35 (0.43) 3.43 ± 0.48 (0.39) 32.12 ± 1.19 (0.83) 31.84 ± 2.36 (<0.40) 3.38 ± 0.32 (5.76)
HepG2 Degree of resistance 7.54 ± 0.55 (3.87) 6.84 ± 0.64 (4.26) >80 >80 2.12 ± 0.52 (>37.74)
AML12 29.18 ± 3.03 29.14 ± 2.17 >80 >80 >80
aThe degree of resistance was determined as the ratio of IC50 value in the resistant divided by the IC50 in the sensitive cell line; CEM/ADR5000, MDA-MB-231-BCRP,
HCT116 (p53−/−), U87MG.ΔEGFR and AML12 were used as the corresponding resistant counterpart for CCRF-CEM (Table 1), MDA-MB-231-pcDNA, HCT116 (p53+/+),
U87MG and HepG2 cells, respectively. The tested methanol extracts were from AAB Albizia adianthifolia bark, AAR Albizia adianthifolia roots, ACL Alchornea cordifolia
leaves, ACB Alchornea cordifolia bark. In bold: significant cytotoxic effects. Leukemia CEM/ADR5000 cells were tested in RPMI 1640 medium while carcinoma cells tested



























































































































Fig. 1 Cell cycle distribution of CCRF-CEM leukemia cells treated with extracts from Albizia adianthifolia roots (AAR), Alchornea cordifolia leaves
(ACL) or doxorubicin (control drug) at different time. AAR and ACL were tested at 0.98 μg/mL and 8.02 μg/mL respectively, while doxorubicin
was tested at 0.11 μg/mL corresponding to their IC50 values. At each experimental time (24 h, 48 h, 72 h), data with different superscript letters
are significantly different (P < 0.05)
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Discussion
The development of resistance by malignant cells remains
a serious issue in cancer chemotherapy. Cancer cells rap-
idly develop chemoresistance, mainly due to the presence
of adenosine triphosphate-binding cassette (ABC) trans-
porters [2–4], such as the breast cancer resistance protein
(BCRP/ABCG2) and P-glycoprotein (P-gp/MDR1/ABCB1)
[2] as well as the oncogene epidermal growth factor recep-
tor (EGFR) [3, 4, 27] and the deletion or inactivation of
tumor suppressor gene p53 [5]. Hence, identifying the
mechanisms of resistance to different drugs is necessary,
in order to efficiently prevent and overcome drug resist-
ance. In this study, multi-factorial drug-resistant cancer
cell lines such as leukemia CEM/ADR5000 cells over-
expressing P-glycoprotein, breast adenocarcinoma MDA-
MB-231-BCRP clone 23 expressing BCRP, p53 knockout
HCT116 (p53−/−) colon cancer cells and EGFR-transfected
U87MG.ΔEGFR glioblastoma cells [4, 7, 12, 20–22, 28]
were used to determine to assess the cytotoxicity the se-
lected plant extracts. According to the US NCI plant
screening program, botanicals with IC50 values below of
20 μg/mL following incubation between 48 and 72 h [29]
have been recognized as potential cytotoxic substances. In
preliminary assays using the sensitive leukemia CCRF-
CEM cells, AAB, AAR, ACL and ACB (Table 2) displayed
IC50 values below 20 μg/mL and were therefore selected
for further assays against MDR phenotypes of other cell
lines. Interestingly, AAB and AAR also displayed IC50
values below or around 10 μg/mL and could therefore be
considered as potential source for novel anti-cancer drugs.
Most importantly, the degree of resistance of cells lines to
AAB and AAR were in all cases lower than that of
doxorubicin, highlighting their potential to combat MDR
phenotypes. Though the IC50 values recorded with ACL
and ACB were all above 20 μg/mL, the cytotoxicity of
these two samples on malignant cells can still be consid-
ered interesting, as they were much less toxic on normal
AML12 hepatocytes, highlighting their good selectivity. It
is also worth to note that the two best extracts, AAB and
AAR were slightly toxic to normal AML12 hepatocytes
(IC50 values of 29.18 μg/mL and 29.14 μg/mL respectively
for AAB and AAR). However, their high cytotoxicity to-
wards cancer cells also suggests that they might be safely
used in cancer chemotherapy. However, further evidence
of the clinical efficacy of these extracts will be needed, as
many phytochemicals are poorly bioavailable and they may
be metabolized to more or less potent compounds by gut
bacterial metabolism. MMP loss and increased ROS have
been reported as a mode of apoptosis induction of plant
extracts [29]. Hence, the ability of AAR and ACL to cause
MMP breakdown in CCRF-CEM cells fits to this theory.
The mode of action of AAR also includes the activation of
caspases. Initiator caspases 9 (2.02-fold) and effector cas-
pases 3/7 (4.35-fold) (Fig. 2) were significantly activated
[29]. In addition to MMP alterations, ACL-induced apop-
tosis also include ROS production (Fig. 4).
To the best of our knowledge, the cytotoxicty of Albi-
zia adiathifolia and Alchornea cordifolia towards the cell
line panel tested in this study is being reported for the
first time. Triterpenoid saponins such as adianthifolio-
sides A, B, and D isolated from Albizia adianthifolia
exhibited cytotoxic effects towards Jurkat leukemia cells
[30]. The presence of these compounds as well as other
































caspase 3/7 caspase 8 caspase 9
Fig. 2 Enzymatic activity of caspase 3/7, caspase 8 and caspase 9 after 6 h treatment of CCRF-CEM cells with AAR and ACL extracts. The activity
of caspase is expressed as percentage % relative to untreated cells. IC50: 0.98 μg/mL and 8.02 μg/mL for AAR and ACL extracts, respectively.
Data with different superscript letters are significantly different (P < 0.05)
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aurantiamide acetate [32] found in Albizia adianthifolia
could explain the antiproliferative effects of this plant.
Conclusion
Twelve extracts from 5 medicinal plants (Albizia adianthi-
folia, Alchornea cordifolia, Alchornea laxiflora, Pennisetum
purpureum, and Spathodea campanulata) displayed cyto-
toxicity against CCRF-CEM leukemia cells. They may
represent a source for the development of novel anticancer
drugs. Furthermore, Albizia adianthifolia and Alchornea
cordifolia further displayed considerable cytotoxicity against
MDR phenotypes in a panel of 8 other cancer cell lines.
They may therefore be exploited to develop phytomedicine
to fight cancers with various MDR phenotypes. AAR and
AAB were the most cytotoxic extracts and the mechanism






Fig. 3 Effect of AAR and ACL extracts on the mitochondrial membrane potential in CCRF-CEM cells. C: control; AAR was tested at 24 h at 0.49 μg/mL
(AAR1), 0.98 μg/mL (AAR2), and 1.96 μg/mL (AAR3), while ACL was tested at 4.01 μg/mL (ACL1), 8.02 μg/mL (ACL2), and 16.04 μg/mL
(ACL3) corresponding to 1/2-fold, IC50 and 2-fold IC50 values. Data for the positive control, vinblastine under similar experimental conditions were
previously reported [7]. Loss of MMP (Q1), intact cells (Q2), ruptured cell membrane (Q3 and Q4)
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caspases activation and MMP loss. The mode of apotosis
induction by ACL extract included MMP disruption and
increased ROS generation in CCRF-CEM cells. The cyto-
toxicty of the two best plants, Albizia adiathifolia and
Alchornea cordifolia towards the cell line panel tested in
this study is being reported for the first time. Their purifica-
tion will further be performed to identify their active
constituents.
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